The Valley Desk

NCT03323151 · Interventional trial

A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

Overall registry status Completed

Phase 1 · Phase 2

Conditions Mantle-Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov